Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Accumulated Depreciation & Amortization (2016 - 2020)

Historic Accumulated Depreciation & Amortization for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $284000.0.

  • Larimar Therapeutics' Accumulated Depreciation & Amortization changed N/A to $284000.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $284000.0, marking a year-over-year change of. This contributed to the annual value of $179000.0 for FY2019, which is 6745.45% down from last year.
  • Per Larimar Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $284000.0 for Q3 2020.
  • Larimar Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $550000.0 during Q4 2018, with a 5-year trough of $179000.0 in Q4 2019.
  • Its 5-year average for Accumulated Depreciation & Amortization is $345833.3, with a median of $302000.0 in 2016.
  • As far as peak fluctuations go, Larimar Therapeutics' Accumulated Depreciation & Amortization surged by 16666.67% in 2016, and later plummeted by 6745.45% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $320000.0 in 2016, then skyrocketed by 58.75% to $508000.0 in 2017, then rose by 8.27% to $550000.0 in 2018, then crashed by 67.45% to $179000.0 in 2019, then skyrocketed by 58.66% to $284000.0 in 2020.
  • Its Accumulated Depreciation & Amortization was $284000.0 in Q3 2020, compared to $234000.0 in Q2 2020 and $179000.0 in Q4 2019.